Lifeboat Foundation

Today at 1 PM PST.

On Sunday, February 212021, at 1 p.m. U.S. Pacific Time, the U.S. Transhumanist Party invites Dr. Aubrey de Grey of the SENS Research Foundation, for an in-depth conversation about recent developments in the quest to reverse the damage of biological aging. The discussion will cover current in rejuvenation research and advocacy, as well as delve into how the prospects for reaching longevity escape velocity have changed since Dr. de Grey’s remarks at the U.S. Transhumanist Party Discussion Panel on Life Extension nearly 4 years ago in 2017.

Continue reading “U.S. Transhumanist Party Virtual Enlightenment Salon with Aubrey de Grey” »

I will look at the idea that all disease could be almost stopped in its tracks with a universal treatment for aging. A lot of people ask when we will cure aging and the answer is it may well be here sooner than many realise.

It doesn’t matter how good the treatments are that we develop for cancer, heart disease, alzheimers, and any other of a number of the most common ways we finally die, it is really just a game of whack a mole. If you survive one, just wait a few years and another will get you.

Continue reading “An End To Aging — The Mother Of All Disease” »

Biomedical gerontologist Aubrey de Grey, who’s Chief Science Officer of the SENS Research Foundation, is now predicting a 50% chance that people will begin retaining their youthful state via advanced science and technologies by the year 2036.

This is roughly around the same timeline that The Last Generation to Die is based on. Nailed it (hopefully)!

who’s Chief Science Officer of the SENS Research Foundation, is now predicting a 50% chance that people will begin retaining their youthful state via advanced science and technologies by the year 2036.

This is roughly around the same timeline that The Last Generation to Die is based on. Nailed it (hopefully)!

By 2050, the number of adults over the age of 65 globally will double, reaching a staggering 1.6 billion, with the largest growth in the developing world. This growth will be one of the greatest social, economic, and political transformations of our time, that will impact existing healthcare, government and social systems, that today are largely not inclusive of the ageing population or built to the scale needed to support it.

But we can begin to make investments in our support systems (enabled and scaled by technology) that encompass a coordinated response from governments, society, academia, and the private sector.

Continue reading “Ageing: Looming crisis or booming opportunity?” »

Following in my recent series on subjects that are all the rage in anti-aging and longevity circles, to help you get a good grasp of the essentials so you can know what all the talk is about, and can make informed judgements rather than just following the herd blindly. This time it is on Metformin. This is a drug widely known as a diabetes drug and it has been in use for a very long time, indeed it is one of the most prescribed drugs there is. Recently it has also been a buzz word in the anti aging/longevity communities following the review of data and with it s mechanism of action, being touted and recommended by a variety of voices in the public domain. But how does it work, and how could it improve longevity? Is it safe? Well, if you want to go into a bit more depth and know all the details, I have put together a video which helps you understand what all the fuss is about. And whatever you are doing, have a great day.

Metformin is very popular in the anti aging paradigm currently so let’s have a look at what it is, what it offers, and what the trade offs are… because, well, it is always wise to have all the data.

Continue reading “Metformin Mechanism Of Action” »

In this episode of Lifespan News:

Binary Clock Predicts Biological Age Longevity company funding roundup Lifespan.io just turned 7 CAR T-cell therapy generates lasting remissions in patients with multiple myeloma CBD Reduces Plaque and Improves Cognition in Model of Familial Alzheimer’s.

Might interest some, mentions telomeres.

~~~

Aging is a common factor in many diseases. So, what if it were possible to treat them by acting on the causes of aging or, more specifically, by acting on the shortening of telomeres, the structures that protect chromosomes? This strategy is being pursued by the Telomeres and Telomerase Group of the Spanish National Cancer Research Centre (CNIO), which has already succeeded in curing pulmonary fibrosis and infarctions in mice by lengthening telomeres. Now they take a first step towards doing the same with renal fibrosis by demonstrating that short telomeres are at the origin of this disease, which is also associated with aging.

Continue reading “Researchers investigate treatment of renal fibrosis by showing that it is caused by telomere shortening” »

But such drugs could face a daunting challenge, since aging is not considered a disease. This means the Food and Drug Administration is unlikely to approve a drug for its anti-aging effects, or as a new use for a licensed drug. Also, pharmaceutical companies probably wouldn’t be inclined to develop drugs for that purpose only.

Drugs that can postpone or prevent the onset of debilitating diseases could enhance longevity and provide enormous societal benefits, geroscientists say.